This is a $86,000.00 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs to Visiopharm Corporation, a foreign-owned for-profit organization based in Denmark. The contract is for the provision of TISSUEARRAY, PHENOMAP, and AI SOFTWARE ADD ON products and services. Visiopharm Corporation, through this contract, will supply digital pathology software, digital microscopes, and biomarker analysis systems to support...
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 20, a civilian agency, to Visiopharm Corporation, a foreign-owned for-profit organization. The contract is for VISIOPHARM EXERCISE OPTION YEAR 2 and has a ceiling value of $12,600.00. Visiopharm Corporation is a wholly-owned subsidiary of Visiopharm A/S, a Danish company specializing in precision pathology software and digital microscopy solutions. This contract is not associated with a larger vehicle...
This federal contract award was made by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Visiopharm Corporation, a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions. The $63,750.00 firm-fixed-price purchase order is for VISIOPHARM DIGITAL PATHOLOGY SUBSCRIPTIONS and PHENOPLEX SOFTWARE UPGRADES. The contract did not utilize a set-aside designation. Visiopharm Corporation is a wholly-owned...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Visiopharm Corporation, a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions. The contract is for VISIOPHARM SOFTWARE MAINTENANCE, with a ceiling value of $31,600.00 and a period of performance ending on April 30, 2024. The contract was not set aside for any specific business category. Visiopharm Corporation is a wholly-owned...
Visiopharm Corporation, a foreign-owned for-profit organization, was awarded a $24,775.60 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to deliver software with a completion date of February 14, 2025. The award was made on February 15, 2024 without a set-aside designation. Visiopharm will provide its precision pathology software for research and diagnostics, leveraging over 20 years of experience...
This $97,209.51 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, to Visiopharm Corporation, a foreign-owned for-profit organization specializing in precision pathology software and digital microscopy solutions. The contract is for the provision of HISTOPATHOLOGICAL AI ANALYSIS SOFTWARE, a set-aside for small businesses. Visiopharm, headquartered in Denmark, has over 20 years of...
This $79,800.00 firm-fixed-price purchase order from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) awarded to Visiopharm Corporation, a foreign-owned for-profit organization, provides 12-month licenses for Visiopharm's AI-powered image analysis software, Octotopix, and Translational Research Software. The software will support digital pathology and assist pathologists at the NCI's Laboratory of Pathology in analyzing patient tissue samples and providing more...
The U.S. Defense Health Agency (DHA) awarded a $82,190.00 firm-fixed-price purchase order contract to Visiopharm Corporation for the procurement of OCUS40 digital microscopes. The contract has a completion date of October 29, 2023 and was set aside for total small business participation. Visiopharm Corporation is a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions, and is a wholly-owned subsidiary of the manufacturer Visiopharm...
The National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, awarded a firm-fixed-price purchase order contract to Visiopharm Corporation, a foreign-owned, for-profit organization, for the PHENOPLEX SOFTWARE UPGRADE project. The $46,007.55 contract does not utilize any set-aside designations and has an ultimate completion date of July 31, 2025. Visiopharm Corporation, a provider of precision pathology software and digital microscopy solutions, has secured...
This is a firm fixed-price purchase order awarded to Volpara Health, Inc., a foreign-owned, for-profit manufacturer of medical imaging software and equipment, for the VISN 8 Aspen Breast Upgrade, Maintenance and Support project. The contract, valued at $136,000.00, was awarded by the Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the Department of Veterans Affairs (VA). The contract requires Volpara Health to provide software licenses, integration, customization,...
This federal contract award to Visiopharm Corporation, a foreign-owned, for-profit organization, is for DIGITAL PATHOLOGY ANALYSIS SOFTWARE. The $98,346.00 firm-fixed-price purchase order was awarded by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs. The contract has an ultimate completion date of October 16, 2017 and does not utilize a set-aside designation. Visiopharm Corporation is a subsidiary of Visiopharm A/S, headquartered in Denmark, and has over 20 years of experience developing artificial intelligence and deep learning solutions for digital pathology. Through this contract, Visiopharm will provide specialized software and services to support research and diagnostic efforts across various government health and research institutions, contributing to improved outcomes and patient care.